Adverse Drug Events Recruiting Phase 4 Trials for Aluminum zirconium octachlorohydrex gly (DB11200)

Also known as: Adverse Drug Event

IndicationStatusPhase
DBCOND0029335 (Adverse Drug Events)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs